# Impact of Early and Severe Fetal Growth Restriction on Neurodevelopmental Outcomes in Preterm Infants

> **NCT05381272** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 20 (estimated)

## Conditions studied

- Severe Intra-uterine Growth Restriction
- Preterm Birth
- Neurodevelopmental Disorders
- Placental Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05381272
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05381272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05381272, "Impact of Early and Severe Fetal Growth Restriction on Neurodevelopmental Outcomes in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05381272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*